Archiv: FAQs

ENDOLEASE is delivered minimally invasively via catheter into a target artery. Once in place, the implant releases therapeutic agents in a controlled and sustained manner into the arterial bloodstream, allowing them to be carried downstream into the capillary network of the intended tissue territory.

ENDOLEASE is the first implantable intra-arterial drug delivery platform designed for precision therapy at the site of disease. It enables controlled, localized release of therapeutics directly into the arterial blood flow supplying a defined target tissue, with the goal of improving efficacy while reducing systemic exposure.